Ayako Yukita

837 total citations
12 papers, 724 citations indexed

About

Ayako Yukita is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ayako Yukita has authored 12 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Ayako Yukita's work include Angiogenesis and VEGF in Cancer (7 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Vascular Tumors and Angiosarcomas (2 papers). Ayako Yukita is often cited by papers focused on Angiogenesis and VEGF in Cancer (7 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Vascular Tumors and Angiosarcomas (2 papers). Ayako Yukita collaborates with scholars based in Japan and United States. Ayako Yukita's co-authors include Makoto Asano, Shinichi Kondo, T Matsumoto, Hitoshi Suzuki, Hideo Suzuki, George R. Pettit, Yoshiaki Kamano, Toshiaki Segawa, Keigo Matsumoto and Tatsuo Tanaka and has published in prestigious journals such as Journal of Medicinal Chemistry, International Journal of Cancer and Bioorganic & Medicinal Chemistry.

In The Last Decade

Ayako Yukita

12 papers receiving 702 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ayako Yukita Japan	11	543	224	211	77	71	12	724
András Jeney Hungary	18	438 0.8×	189 0.8×	222 1.1×	69 0.9×	25 0.4×	46	781
Jing‐Wen Bai China	17	572 1.1×	269 1.2×	308 1.5×	159 2.1×	52 0.7×	39	1.0k
Rohit Chugh United States	17	784 1.4×	171 0.8×	311 1.5×	39 0.5×	49 0.7×	30	1.2k
Akiko Tohgo Japan	18	501 0.9×	98 0.4×	526 2.5×	83 1.1×	36 0.5×	37	930
Stella Chai Hong Kong	15	611 1.1×	338 1.5×	367 1.7×	63 0.8×	78 1.1×	20	963
Heng Jiang China	17	419 0.8×	251 1.1×	319 1.5×	129 1.7×	42 0.6×	41	974
Guangchun He China	15	478 0.9×	297 1.3×	323 1.5×	176 2.3×	68 1.0×	25	952
Hisao Fukumoto Japan	17	587 1.1×	129 0.6×	432 2.0×	193 2.5×	22 0.3×	30	1.0k
Dandan Yuan China	17	389 0.7×	153 0.7×	243 1.2×	99 1.3×	48 0.7×	50	792
Jelena Grahovac Serbia	10	471 0.9×	227 1.0×	287 1.4×	110 1.4×	37 0.5×	21	853

Countries citing papers authored by Ayako Yukita

Since Specialization

Citations

This map shows the geographic impact of Ayako Yukita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayako Yukita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayako Yukita more than expected).

Fields of papers citing papers by Ayako Yukita

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayako Yukita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayako Yukita. The network helps show where Ayako Yukita may publish in the future.

Co-authorship network of co-authors of Ayako Yukita

This figure shows the co-authorship network connecting the top 25 collaborators of Ayako Yukita. A scholar is included among the top collaborators of Ayako Yukita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayako Yukita. Ayako Yukita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Kamano, Yoshiaki, Toshihiko Nogawa, Hiroshi Morita, et al.. (2002). QSAR Evaluation of the Ch'an Su and Related Bufadienolides against the Colchicine-Resistant Primary Liver Carcinoma Cell Line PLC/PRF/5. Journal of Medicinal Chemistry. 45(25). 5440–5447. 89 indexed citations

Kawaguchi, Takeo, et al.. (2000). Enzymatic Reactivity and Anti-tumor Activity of 1-(.BETA.-D-Arabinofuranosyl)-2-thiocytosine Derivatives.. Chemical and Pharmaceutical Bulletin. 48(4). 454–457. 10 indexed citations

Yukita, Ayako, Makoto Asano, Takako Okamoto, Shigehiko Mizutani, & Hiroshi Suzuki. (2000). Suppression of ascites formation and re-accumulation associated with human ovarian cancer by an anti-VPF monoclonal antibody in vivo.. PubMed. 20(1A). 155–60. 39 indexed citations

Asano, Makoto, Ayako Yukita, & Hideo Suzuki. (1999). Wide Spectrum of Antitumor Activity of a Neutralizing Monoclonal Antibody to Human Vascular Endothelial Growth Factor. Japanese Journal of Cancer Research. 90(1). 93–100. 49 indexed citations

Kamiya, Kinji, Hiroyuki Konno, Tatsuo Tanaka, et al.. (1999). Antitumor Effect on Human Gastric Cancer and Induction of Apoptosis by Vascular Endothelial Growth Factor Neutralizing Antibody. Japanese Journal of Cancer Research. 90(7). 794–800. 29 indexed citations

Kawaguchi, Takeo, Tetsuya Hasegawa, Mineo Saneyoshi, et al.. (1999). Cytotoxicity and Pharmacokinetics of 1-.BETA.-D-Arabinofuranosyl-2-thiocytosine, a 2-Sulphur Substituted Derivative of Cytarabine.. Biological and Pharmaceutical Bulletin. 22(1). 100–102. 4 indexed citations

Kamano, Yoshiaki, Masuo Inoue, Hiroshi Morita, et al.. (1998). Structure–cytotoxic activity relationship for the toad poison bufadienolides. Bioorganic & Medicinal Chemistry. 6(7). 1103–1115. 112 indexed citations

Konno, Hiroyuki, Tatsuo Tanaka, Keigo Matsumoto, et al.. (1998). Anti-tumor and anti-metastatic effects of human-vascular-endothelial-growth-factor-neutralizing antibody on human colon and gastric carcinoma xenotransplanted orthotopically into nude mice. International Journal of Cancer. 77(6). 933–936. 81 indexed citations

Konno, Hiroyuki, Tomio Arai, Tatsuo Tanaka, et al.. (1998). Antitumor Effect of a Neutralizing Antibody to Vascular Endothelial Growth Factor on Liver Metastasis of Endocrine Neoplasm. Japanese Journal of Cancer Research. 89(9). 933–939. 39 indexed citations

10.

Asano, Makoto, et al.. (1998). An Anti-Human VEGF Monoclonal Antibody, MV833, That Exhibits Potent Anti-Tumor Activity In Vivo. Hybridoma. 17(2). 185–190. 38 indexed citations

11.

Asano, Makoto, et al.. (1995). Isolation and Characterization of Neutralizing Monoclonal Antibodies to Human Vascular Endothelial Growth Factor/Vascular Permeability Factor ₁₂₁ (VEGF/VPF ₁₂₁ ). Hybridoma. 14(5). 475–480. 18 indexed citations

12.

Asano, Makoto, Ayako Yukita, T Matsumoto, Shinichi Kondo, & Hitoshi Suzuki. (1995). Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor121.. PubMed. 55(22). 5296–301. 216 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact